Low doses of common cancer drug may promote cancer spread

New research indicates that paclitaxel, which is the most commonly used chemotherapy for breast cancer, suppresses tumors when given at a certain dosage, but at low doses, it actually promotes cancer spread to the liver.

The findings suggest that lowering the dose of to reduce toxic side-effects is not a safe strategy.

"Paclitaxel and its analogous compounds are the first line agents widely used in clinical cancer chemotherapy. However, potential risks and reasonable treatment strategies ofpaclitaxel continue to be widely investigated," wrote the authors of The FEBS Journal study.

Explore further

Study shows low-dose chemo keeps cancer under control

More information: Qi Li et al, Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model, The FEBS Journal (2016). DOI: 10.1111/febs.13767
Provided by Wiley
Citation: Low doses of common cancer drug may promote cancer spread (2016, June 22) retrieved 1 March 2021 from https://medicalxpress.com/news/2016-06-doses-common-cancer-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments